Table_1_FMT intervention decreases urine 5-HIAA levels: a randomized double-blind controlled study.DOCX by Lihong Wang (14991)

“…However, in the placebo group, GSRS, CARS, and SRS scores showed no significant changes, while ABC scores decreased from 72 to 58.75 (p = 0.034). The FMT group also showed a significant reduction in urinary 5-hydroxyindoleacetic acid (5-HIAA) levels from 8.6 to 7.32 mg/L (p = 0.022), while other metabolites showed no significant changes.…”

Video5_Aging, not Parkinson’s disease, decreases a recalibration of body ownership caused by vision-respiratory interaction.MP4 by Daiki Shoji (18283906)

Decreased expression of 5-HT_2A receptors but not of PSD-95 in spinal cord of carrageenan-injected rats. by Anne-Sophie Wattiez (460341)

DataSheet_1_Decreased expression of SCARA5 predicts a poor prognosis in melanoma using bioinformatics analysis.xlsx by Qinggan Ni (14835463)

“…Background<p>It has been established that the scavenger receptor class A member 5 (SCARA5) functions as a tumor suppressor gene in various cancer types. …”

p12 carries a signal peptide that is cleaved via the signal peptidase complex (SPC). by Florian Simon (5387228)

EMBS-treated cells undergo apoptosis correlated with decreased cell viability, metabolic activity and mitochondrial membrane potential. by Michelle Helen Visagie (3927308)

S5 Table - by Mohamad Karaky (8910497)

Subjects:

Effect of thalidomide on expression and cellular localization of CUL5 in control RAMEC and RAMEC transfected with ^S730ACUL5. by Bryan Kunkler (5204327)

Annexin A2 accumulates in the nucleus and decreases in the cytoplasm in response to genotoxic agents. by Patricia A. Madureira (114480)

Mutation of <i>talB</i> in BAI3 results in a decrease of virulence partially complemented by the induction of <i>OsERF#123</i>. by Tuan T. Tran (5335004)

Supplementary Videos (File S3) show a step-by-step protocol for preparing and connecting <i>Apis mellifera</i> workers to the electrical measurement system. by Juan P. Hernández (22216133)

Fig 7 - by Kalman F. Szucs (19353218)

Subjects:

Vaginal impedance values measured with the estrus cycle monitor before and after 7 days of cetrorelix treatment (Fig 2). by Kalman F. Szucs (19353218)

Subjects:

Maximum values of power spectrum density in 2 different groups of rats detected by in vivo smooth muscle electromyography (Fig 4). by Kalman F. Szucs (19353218)

Subjects:

The average radiant efficiency values in equally sized regions of interest of the non-pregnant uterus in the control and cetrorelix treated rats (Fig 6). by Kalman F. Szucs (19353218)

Subjects:

Inner medullary expression of the V2 vasopressin receptor. by Sophie Constantin Lütken (689916)

Subjects:

Average radiant efficiency (± SEM) in equally sized regions of interest (ROIs) of the non-pregnant uterus. by Kalman F. Szucs (19353218)

Subjects:

Vaginal impedance (± SEM) values measured with the estrus cycle monitor. by Kalman F. Szucs (19353218)

Subjects:

Effects of cetrorelix treatment on changes in the KCl-evoked contractions of the non-pregnant uterus (U) and the cecum (C). by Kalman F. Szucs (19353218)

Subjects:

Effects of cetrorelix treatment on changes in spontaneous contractions of the non-pregnant uterus (U) and the cecum (C). by Kalman F. Szucs (19353218)

Subjects: